ELV Quantitative Stock Analysis

Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy, has assigned Elevance Health (ELV) an 81% rating, signifying "some interest" in the large-cap health insurer. This quantitative assessment, which prioritizes low volatility alongside strong momentum and high net payout yields, indicates a favorable fundamental and valuation outlook for ELV within this risk-averse, factor-based framework, despite some individual criteria registering as neutral.

Analysis

Elevance Health (ELV) has been assigned a favorable 81% rating by Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy of targeting low-volatility stocks with strong momentum and high net payout yields. This score suggests the large-cap health insurer meets the general profile for this specific quantitative screen. The analysis indicates that ELV successfully passes the model's tests for market capitalization and standard deviation, confirming its low-risk characteristics. However, the report presents a mixed picture, as the stock receives neutral ratings for both its 'Twelve Minus One Momentum' and 'Net Payout Yield'. This suggests that while stable, its recent price performance and capital return profile are not strong enough to be considered a primary driver. Most notably, despite the high overall score, the stock is given a 'FAIL' on the 'FINAL RANK' criterion, indicating a significant contradiction that suggests it does not meet a key threshold within the model's final evaluation, despite its positive attributes in volatility.

Key Decisions for Investors

• Investors prioritizing a low-volatility strategy may find ELV's 'PASS' on standard deviation appealing, but should note the lack of strong momentum and yield factors.
• The conflicting 'FAIL' on the final rank despite a high 81% score warrants caution, suggesting the stock should be viewed as a candidate for further due diligence rather than an outright buy based on this model alone.
• Traders and factor-based investors should investigate the components of the 'Net Payout Yield' and 'Momentum' scores to understand why a low-risk company is not exhibiting stronger signals in these areas before initiating a position.